Allergan $639 million acquisition of Vitae

Overview:

• Allergan has acquired fellow pharmaceutical company Vitae in a $639 million deal.
• The price tag comes to $27 per Vitae share.
• The purchase adds Vitae's dermatology and autoimmune products to Allergan's pipeline.
• Allergan is headquartered in Dublin, Ireland.
• Debevoise & Plimpton (Andrew Bab) advised Allergan.
• Gunderson Dettmer Stough Villeneuve Franklin & Hachigian (Jay Hachigian, Andrew Luh, Gregg Griner) advised Vitae.

Kurt Stumpo - Journalist - North America and the Caribbean